Literature DB >> 33513134

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo.

Ronald E Crump1,2,3, Ching-I Huang1,2, Edward S Knock1,4, Simon E F Spencer1,4, Paul E Brown1,2, Erick Mwamba Miaka5, Chansy Shampa5, Matt J Keeling1,2,3, Kat S Rock1,2.   

Abstract

Gambiense human African trypanosomiasis (gHAT) is a virulent disease declining in burden but still endemic in West and Central Africa. Although it is targeted for elimination of transmission by 2030, there remain numerous questions about the drivers of infection and how these vary geographically. In this study we focus on the Democratic Republic of Congo (DRC), which accounted for 84% of the global case burden in 2016, to explore changes in transmission across the country and elucidate factors which may have contributed to the persistence of disease or success of interventions in different regions. We present a Bayesian fitting methodology, applied to 168 endemic health zones (∼100,000 population size), which allows for calibration of a mechanistic gHAT model to case data (from the World Health Organization HAT Atlas) in an adaptive and automated framework. It was found that the model needed to capture improvements in passive detection to match observed trends in the data within former Bandundu and Bas Congo provinces indicating these regions have substantially reduced time to detection. Health zones in these provinces generally had longer burn-in periods during fitting due to additional model parameters. Posterior probability distributions were found for a range of fitted parameters in each health zone; these included the basic reproduction number estimates for pre-1998 (R0) which was inferred to be between 1 and 1.14, in line with previous gHAT estimates, with higher median values typically in health zones with more case reporting in the 2000s. Previously, it was not clear whether a fall in active case finding in the period contributed to the declining case numbers. The modelling here accounts for variable screening and suggests that underlying transmission has also reduced greatly-on average 96% in former Equateur, 93% in former Bas Congo and 89% in former Bandundu-Equateur and Bandundu having had the highest case burdens in 2000. This analysis also sets out a framework to enable future predictions for the country.

Entities:  

Mesh:

Year:  2021        PMID: 33513134      PMCID: PMC7899378          DOI: 10.1371/journal.pcbi.1008532

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  32 in total

1.  A global sensitivity analysis for African sleeping sickness.

Authors:  Stephen Davis; Serap Aksoy; Alison Galvani
Journal:  Parasitology       Date:  2010-11-16       Impact factor: 3.234

2.  The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.

Authors:  Pere P Simarro; Giuliano Cecchi; Massimo Paone; José R Franco; Abdoulaye Diarra; José A Ruiz; Eric M Fèvre; Fabrice Courtin; Raffaele C Mattioli; Jean G Jannin
Journal:  Int J Health Geogr       Date:  2010-11-01       Impact factor: 3.918

3.  Data-driven models to predict the elimination of sleeping sickness in former Equateur province of DRC.

Authors:  K S Rock; A Pandey; M L Ndeffo-Mbah; K E Atkins; C Lumbala; A Galvani; M J Keeling
Journal:  Epidemics       Date:  2017-03       Impact factor: 4.396

4.  Control and surveillance of human African trypanosomiasis.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2013

5.  Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo.

Authors:  Kat S Rock; Steve J Torr; Crispin Lumbala; Matt J Keeling
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

6.  Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program.

Authors:  Mariame Camara; Eric Ouattara; Alexandre Duvignaud; René Migliani; Oumou Camara; Mamadou Leno; Philippe Solano; Bruno Bucheton; Mamadou Camara; Denis Malvy
Journal:  PLoS Negl Trop Dis       Date:  2017-11-13

7.  Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad).

Authors:  Mahamat Hissene Mahamat; Mallaye Peka; Jean-Baptiste Rayaisse; Kat S Rock; Mahamat Abdelrahim Toko; Justin Darnas; Guihini Mollo Brahim; Ali Bachar Alkatib; Wilfrid Yoni; Inaki Tirados; Fabrice Courtin; Samuel P C Brand; Cyrus Nersy; Idriss Oumar Alfaroukh; Steve J Torr; Mike J Lehane; Philippe Solano
Journal:  PLoS Negl Trop Dis       Date:  2017-07-27

8.  Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium.

Authors:  Matthew R Behrend; María-Gloria Basáñez; Jonathan I D Hamley; Travis C Porco; Wilma A Stolk; Martin Walker; Sake J de Vlas
Journal:  PLoS Negl Trop Dis       Date:  2020-04-09

9.  Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo.

Authors:  Inaki Tirados; Andrew Hope; Richard Selby; Fabrice Mpembele; Erick Mwamba Miaka; Marleen Boelaert; Mike J Lehane; Steve J Torr; Michelle C Stanton
Journal:  PLoS Negl Trop Dis       Date:  2020-10-16

10.  Reducing Human-Tsetse Contact Significantly Enhances the Efficacy of Sleeping Sickness Active Screening Campaigns: A Promising Result in the Context of Elimination.

Authors:  Fabrice Courtin; Mamadou Camara; Jean-Baptiste Rayaisse; Moise Kagbadouno; Emilie Dama; Oumou Camara; Ibrahima S Traoré; Jérémi Rouamba; Moana Peylhard; Martin B Somda; Mamadou Leno; Mike J Lehane; Steve J Torr; Philippe Solano; Vincent Jamonneau; Bruno Bucheton
Journal:  PLoS Negl Trop Dis       Date:  2015-08-12
View more
  11 in total

1.  Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study.

Authors:  Anna Borlase; Epke A Le Rutte; Soledad Castaño; David J Blok; Jaspreet Toor; Federica Giardina; Emma L Davis
Journal:  Lancet Glob Health       Date:  2022-11       Impact factor: 38.927

2.  Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo.

Authors:  Christopher N Davis; Kat S Rock; Marina Antillón; Erick Mwamba Miaka; Matt J Keeling
Journal:  BMC Med       Date:  2021-04-01       Impact factor: 8.775

3.  The cost of tsetse control using 'Tiny Targets' in the sleeping sickness endemic forest area of Bonon in Côte d'Ivoire: Implications for comparing costs across different settings.

Authors:  Fabrice Courtin; Dramane Kaba; Jean-Baptiste Rayaisse; Philippe Solano; Steve J Torr; Alexandra P M Shaw
Journal:  PLoS Negl Trop Dis       Date:  2022-01-05

4.  Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad.

Authors:  Kat S Rock; Ching-I Huang; Ronald E Crump; Paul R Bessell; Paul E Brown; Inaki Tirados; Philippe Solano; Marina Antillon; Albert Picado; Severin Mbainda; Justin Darnas; Emily H Crowley; Steve J Torr; Mallaye Peka
Journal:  Infect Dis Poverty       Date:  2022-01-24       Impact factor: 4.520

5.  Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo.

Authors:  Aatreyee M Das; Nakul Chitnis; Christian Burri; Daniel H Paris; Swati Patel; Simon E F Spencer; Erick M Miaka; M Soledad Castaño
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29

6.  Economic evaluation of disease elimination: An extension to the net-benefit framework and application to human African trypanosomiasis.

Authors:  Marina Antillon; Ching-I Huang; Kat S Rock; Fabrizio Tediosi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 11.205

7.  Modelling to explore the potential impact of asymptomatic human infections on transmission and dynamics of African sleeping sickness.

Authors:  Maryam Aliee; Matt J Keeling; Kat S Rock
Journal:  PLoS Comput Biol       Date:  2021-09-13       Impact factor: 4.475

8.  Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo.

Authors:  Kat S Rock; Fabrizio Tediosi; Marina Antillon; Ching-I Huang; Ronald E Crump; Paul E Brown; Rian Snijders; Erick Mwamba Miaka; Matt J Keeling
Journal:  Nat Commun       Date:  2022-02-25       Impact factor: 14.919

9.  How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases.

Authors:  Jessica Clark; Wilma A Stolk; María-Gloria Basáñez; Luc E Coffeng; Zulma M Cucunubá; Matthew A Dixon; Louise Dyson; Katie Hampson; Michael Marks; Graham F Medley; Timothy M Pollington; Joaquin M Prada; Kat S Rock; Henrik Salje; Jaspreet Toor; T Déirdre Hollingsworth
Journal:  Gates Open Res       Date:  2022-02-02

10.  Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo.

Authors:  Ching-I Huang; Ronald E Crump; Paul E Brown; Simon E F Spencer; Erick Mwamba Miaka; Chansy Shampa; Matt J Keeling; Kat S Rock
Journal:  Nat Commun       Date:  2022-03-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.